Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Identification of a novel inhibitor of NleA, an essential virulence factor in enterohaemorrhagenic and enteropathogenic Escherichia coli

FY 2010-11

Summary
Harmless strains of Escherichia coli colonize the human gastrointestinal tract hours after birth and become an integral part of our normal intestinal flora. However, some E. coli strains, such as enteropathogenic E. coli (EPEC) and enterohemorrhagic (EHEC) E. coli, have evolved in such a way as to induce serious disease in humans and are now a widespread and increasingly important public health issue. EPEC is a diarrheal pathogen that kills several hundred thousand children a year in the developing world, while EHEC is a prevalent food contaminant in developed countries, causing disease with potentially fatal complications. We have identified a bacterial protein, NleA, that is present in EPEC and EHEC, but absent from innocuous strains of E. coli. Furthermore, deletion of this protein in harmful strains of E. coli greatly reduces their ability to cause disease. NleA interacts with and inhibits a human protein, Sec24, and this disruption is speculated to be responsible for the detrimental effects of NleA. The proposed project is aimed at screening tens of thousands of small molecules to identify possible compounds which disrupt the NleA-Sec24 interaction. Identification of these compounds will serve as stepping stones in the creation of new drugs for EHEC and EPEC infections.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
225077
Name
Mimee Mark
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Identification of a novel inhibitor of NleA, an essential virulence factor in enterohaemorrhagenic and enteropathogenic Escherichia coli
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bacterial Pathogenesis; Bimolecular Fluorescence Complementation; Ehec And Epec; Gastrointestinal Disease; High Throughput Screen; Protein-Protein Interaction
Abstract
Harmless strains of Escherichia coli colonize the human gastrointestinal tract hours after birth and become an integral part of our normal intestinal flora. However, some E. coli strains, such as enteropathogenic E. coli (EPEC) and enterohemorrhagic (EHEC) E. coli, have evolved in such a way as to induce serious disease in humans and are now a widespread and increasingly important public health issue. EPEC is a diarrheal pathogen that kills several hundred thousand children a year in the developing world, while EHEC is a prevalent food contaminant in developed countries, causing disease with potentially fatal complications. We have identified a bacterial protein, NleA, that is present in EPEC and EHEC, but absent from innocuous strains of E. coli. Furthermore, deletion of this protein in harmful strains of E. coli greatly reduces their ability to cause disease. NleA interacts with and inhibits a human protein, Sec24, and this disruption is speculated to be responsible for the detrimental effects of NleA. The proposed project is aimed at screening tens of thousands of small molecules to identify possible compounds which disrupt the NleA-Sec24 interaction. Identification of these compounds will serve as stepping stones in the creation of new drugs for EHEC and EPEC infections.
Competitiondate
201102
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mimee, Mark
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~